Evidence map›Paper›PMID 32083657›Full record

ArticleNucleic acids research2020

Broadly applicable oligonucleotide mass spectrometry for the analysis of RNA writers and erasers in vitro.

Felix Hagelskamp, Kayla Borland, Jillian Ramos, Alan G Hendrick, Dragony Fu, Stefanie Kellner

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Direct sequencing of totalRNA (New York, N.Y.) · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Opportunities and Challenges to Profile mRNA Modifications in Escherichia coli.Chembiochem : a European journal of chemical biology · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Strategies to Avoid Artifacts in Mass Spectrometry-Based Epitranscriptome Analyses.Angewandte Chemie (International ed. in English) · 2021
    Article
  17. Article
  18. mInternational journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Felix HagelskampDepartment of Chemistry, Ludwig Maximilians University Munich, Butenandtstrasse 5-13, 81377 Munich, Germany.
Kayla BorlandDepartment of Chemistry, Ludwig Maximilians University Munich, Butenandtstrasse 5-13, 81377 Munich, Germany.
Jillian RamosDepartment of Biology, Center for RNA Biology, University of Rochester, Rochester, NY 14627, USA.
Alan G HendrickSTORM Therapeutics, Moneta Building, Babraham Research Campus, Cambridge CB22 3AT UK.
Dragony FuDepartment of Biology, Center for RNA Biology, University of Rochester, Rochester, NY 14627, USA.
Stefanie KellnerDepartment of Chemistry, Ludwig Maximilians University Munich, Butenandtstrasse 5-13, 81377 Munich, Germany.
Ludwig-Maximilians-Universität München · DEUniversity of Rochester · US

Funding

VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI Martha Susiarjo · 1985 to 2026
$42.8M
NIEHS NIH HHS P30 ES001247
6 · The paper itself

Abstract

RNAs are post-transcriptionally modified by dedicated writer or eraser enzymes that add or remove specific modifications, respectively. Mass spectrometry (MS) of RNA is a useful tool to study the modification state of an oligonucleotide (ON) in a sensitive manner. Here, we developed an ion-pairing reagent free chromatography for positive ion detection of ONs by low- and high-resolution MS, which does not interfere with other types of small compound analyses done on the same instrument. We apply ON-MS to determine the ONs from an RNase T1 digest of in vitro transcribed tRNA, which are purified after ribozyme-fusion transcription by automated size exclusion chromatography. The thus produced tRNAValAAC is substrate of the human tRNA ADAT2/3 enzyme and we confirm the deamination of adenosine to inosine and the formation of tRNAValIACin vitro by ON-MS. Furthermore, low resolution ON-MS is used to monitor the demethylation of ONs containing 1-methyladenosine by bacterial AlkB in vitro. The power of high-resolution ON-MS is demonstrated by the detection and mapping of modified ONs from native total tRNA digested with RNase T1. Overall, we present an oligonucleotide MS method which is broadly applicable to monitor in vitro RNA (de-)modification processes and native RNA.

Indexed as

Mass SpectrometryRNA Processing, Post-TranscriptionalAdenosineAdenosine DeaminaseChromatography, GelHEK293 CellsHeLa CellsHumansMixed Function OxygenasesOligonucleotidesRibonuclease T1RNA-Binding ProteinsRNA, TransferRNA, Transfer, Val1-methyladenosineADAT2 protein, humanADAT3 protein, humanAdenosineAdenosine DeaminaseMixed Function OxygenasesOligonucleotidesRibonuclease T1RNA-Binding ProteinsRNA, TransferRNA, Transfer, Val

Identifiers

PMID32083657
PMCPMC7144906
OpenAlexW3007606971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.